The Energy Code

By Dr. Mike BelkowskiAlternative Health Health & Fitness

Favorites
50
Followers
Typical duration
55 min
per episode

Based on Podcast App listening data

The Energy Code episodes

May 09Berries, Coffee, and Biohacking: Plant Compounds That Rebuild (or Break) Your Mitochondria
What if the spinach in your salad, the berries in your smoothie, and the caffeine in your coffee aren’t “fuel” at all — but evolved plant defense chemicals that can directly modify your mitochondria? In this deep dive, we unpack a 2025 paper from the International Journal of Molecular Sciences (“Plant Secondary Metabolites as Modulators of Mitochondrial Health”) and follow the mechanisms step-by-step: how mitochondria maintain themselves through biogenesis, fusion/fission, and mitophagy; how compounds like berberine can trigger a controlled “fake energy crisis” to induce cleanup + rebuilding; how caffeine can interrupt apoptosis signaling under UV stress; why astaxanthin can reducemitophagy during acute oxidative panic to prevent cellular self-cannibalism; and why some “plant” benefits (like urolithin A) depend entirely on your gut microbiome. Finally, we hit the paradox: these same metabolites can become selectively cytotoxic to cancer cells—or become dangerous when isolated into high-dose supplements, with real toxicity and drug-interaction risk. The takeaway: food isn’t just calories — it’s environmental code.
(Educational content only, not medical advice.)
-
Article Discussed in Episode:
Plant Secondary Metabolites as Modulators of Mitochondrial Health: An Overview of Their Anti-Oxidant, Anti-Apoptotic, and Mitophagic Mechanisms
-
Key Quotes From Dr. Mike:
“The spinach in your salad… the berries in your smoothie… and even the caffeine in your morning coffee were actually highly evolved chemical weapons.”
“We really have to stop thinking of plants just as vitamins and start looking at them as complex chemical defense systems.”
“Berberine… creates a fake crisis to force an upgrade.”
“Caffeine… effectively jams the self-destruct button.”
“Think of the plant compounds you consume as environmental software updates.”
-
Key Points
Mitochondria aren’t static batteries — they’re a dynamic fleet: biogenesis, fusion, fission, mitophagy.
Mitophagy failure → exhaust (ROS), DNA damage, and programmed cell death pathways that show up in chronic disease.
Plant secondary metabolites evolved as defense chemistry — but “keys fit locks” due to shared ancient biochemical language.
Berberine: induces a mild energy dip → triggers mitophagy + biogenesis (cleanup + upgrade loop).
Caffeine: can intercept UV-stress death signaling, helping cells survive and repair rather than self-destruct.
Astaxanthin: can stabilize membranes and dial back runaway mitophagy during acute oxidative crises.
Urolithin A: you can’t “eat it” — your gut bacteria must manufacture it from ellagitannins.
Cancer paradox: some compounds become targeted demolition in tumor cells due to their altered mitochondrial state.
Dose + context rule everything: isolate + concentrate → membrane damage, ETC disruption, toxicity, interactions.
Big frame: plant compounds are “software updates” for mitochondrial stress resilience.
-
Episode timeline
0:00–1:41 — Hook: food as “chemical weapons” + intro to the 2025 paper + why mitochondria = longevity bedrock
1:41–7:32 — Mitochondrial maintenance 101: biogenesis → fusion/fission → mitophagy “scrapyard” + what failure looks like
7:32–8:56 — Why plant defenses work on us: shared biochemical “locks and keys” across evolution
8:56–11:30 — Alkaloids: berberine (fake crisis → cleanup + rebuild) + caffeine (UV stress apoptosis interception)
11:30–12:55 — Terpenoids: astaxanthin as a membrane stabilizer that prevents panic-mode self-destruction
12:55–16:11 — Polyphenols + the microbiome bottleneck: urolithin A as a bacteria-made mitochondrial “hardware upgrade”
16:11–18:42 — Cancer paradox: same compounds protect healthy cells but can trigger apoptosis in tumor cells (betanin, saponins)
18:42–21:45 — The danger zone: dose escalation, “soap-like” saponin toxicity, high-dose THC/CBD ETC blockade, supplement risks + St. John’s Wort interactions
21:45–24:16 — Synthesis: food as environmental software updates + closing punchline (berries/walnuts/coffee = “security patch”)
-
Dr. Mike's #1 recommendations:
Deuterium depleted water: Litewater (code: DRMIKE)

EMF-mitigating products: Somavedic (code: BIOLIGHT)

Blue light blocking glasses: Ra Optics (code: BIOLIGHT)

Grounding products: Earthing.com
-
Stay up-to-date on social media:
Dr. Mike Belkowski:
Instagram
LinkedIn

BioLight:
Website
Instagram
YouTube
Facebook
25 min
May 08Is Light Therapy Racially Biased? The Melanin Problem PBM Won’t Talk About
Photobiomodulation therapy (PBMT) is marketed like universal biology: shine the right wavelength, hit cytochrome c oxidase, boost ATP, accelerate healing. But this Deep Dive unpacks a hidden variable that can make “standard dosing” either ineffective or unsafe: melanin. Using a 2026 narrative review from researchers at the University of São Paulo, we trace the physics of a photon entering the body, how melanin’s absorption overlaps the therapeutic “optical window,” and why simply “turning up the laser” can backfire — creating heat and reactive species in the epidermis while deeper target tissues get little benefit. We also confront a data problem: trials may include darker phototypes, but too often outcomes aren’t analyzed by skin type, creating a misleading “average” that masks risk. Finally, we outline practical fixes — wavelength selection, spot size adjustments, and pigmentation-sensitive, feedback-guided dosimetry — so PBMT can become truly personalized and equitable.
(Educational content only, not medical advice.)
-
Article Discussed in Episode:
Is photobiomodulation therapy free from racial bias?: a narrative review of skin pigmentation
-
Key Quotes From Dr. Mike:
Regarding melanin: “It literally absorbs the photons before they can ever reach the deeper tissues.”
“For individuals with darker skin tones, this can result in totally subtherapeutic treatments.”
“They currently do not differentiate dosing parameters based on skin pigmentation.”
“The physics of a photon is constant. But the biological filter it’s passing through is wildly diverse.”
“At 660 nm… 21 mm in lighter skin… but in darker skin it drops to 14 mm.”
“We need to stop treating light therapy like a one-size-fits-all t-shirt… and treat it like a custom tailored suit.”
-
Key Points
PBMT’s core mechanism: photons → mitochondrial chromophores (cytochrome c oxidase) → ATP support and healing.
The optical window (≈600–1100 nm) overlaps with melanin’s strong absorption (≈600–900 nm).
Darker skin = more melanin absorption, meaning less light reaches deeper tissue → risk of subtherapeutic dosing.
“Just increase power” can be dangerous: melanin absorbs more energy → heat + ROS/RNS → redness, pain, burns.
Guideline gap: WALT dosing recommendations don’t meaningfully adjust for pigmentation.
Data aggregation problem: studies include darker phototypes but often don’t stratify outcomes, producing “average” conclusions that can hide harm.
Fixes the paper argues for: longer wavelengths (e.g., 830–1064 nm), larger spot sizes, gradual ramping + patient sensory monitoring, and pigmentation-sensitive dosimetry models.
Bottom line: melanin isn’t a deal-breaker — it’s a dosing variable that must be accounted for.
-
Episode timeline
0:19–0:58 — Cold open: expensive PBM devices can still burn patients if not calibrated to skin tone
0:58–1:49 — The core question: Is PBMT free from racial bias? Grounding source + paper title
1:49–2:47 — PBMT basics: cytochrome c oxidase, ATP synthesis, “good biology”
2:47–4:29 — The physics: optical window (600–1100 nm) meets endogenous chromophores; melanin’s peak absorption overlaps therapy
4:29–5:27 — Why darker skin can get subtherapeutic dosing: photons absorbed before reaching target tissue
5:27–7:56 — Why “turn it up” is risky: melanin heat + ROS/RNS → pain, redness, superficial thermal injury (cake/oven analogy)
7:56–10:50 — Guideline + research bias: WALT doesn’t differentiate by pigmentation; studies include darker phototypes but don’t analyze by skin type (“mathematical erasure”)
10:50–12:33 — Solution #1: wavelength selection; penetration example (660 nm vs 830 nm) shows gap narrowing for darker skin
12:33–13:39 — Solution #2–3: larger spot size + gradual increments with sensory monitoring (patient feedback as safety gauge)
13:39–15:27 — Big takeaway: pigmentation-sensitive dosimetry is a necessity; closing question + outro
-
Dr. Mike's #1 recommendations:
Deuterium depleted water: Litewater (code: DRMIKE)

EMF-mitigating products: Somavedic (code: BIOLIGHT)

Blue light blocking glasses: Ra Optics (code: BIOLIGHT)

Grounding products: Earthing.com
-
Stay up-to-date on social media:
Dr. Mike Belkowski:
Instagram
LinkedIn

BioLight:
Website
Instagram
YouTube
Facebook
16 min
May 07Mitophagy: The Cellular Trash Pickup That Decides Your Energy, Aging & Alzheimer’s Risk
Upon Don Bailey's return to the Deep Dive episodes, he and Dr. Mike reframe fatigue, aging, and neurodegeneration through one core process: mitophagy — the cell’s highly selective mitochondrial recycling program. The episode starts with a hard truth: “engineering-style” diagnoses feel comforting, but chronic fatigue and cognitive decline live in a murky zone standard tests rarely capture. From there, the conversation builds a vivid model of mitochondrial energy production (OXPHOS), the unavoidable “exhaust” of ROS, and the multi-tiered quality control stack that keeps your cellular power grid from collapsing: biogenesis (PGC-1α), dynamics (fusion/fission), and mitophagy (the scrapyard).
Then it goes deeper — showing how mitophagy failure can turn mitochondrial damage into neuroinflammation (via leaked bacterial-like mtDNA and the NLRP3 inflammasome) and even “cellular rust” (ferroptosis) when iron-driven lipid peroxidation spirals out of control. The episode also tackles the paradox: mitophagy is protective — until extreme stress pushes it into overdrive, potentially tipping into ferroptosis. Finally, it translates the research into real levers: exercise as hormetic signaling (MICT vs HIIT), the AMPK↔mTOR seesaw, and biohacking tools like urolithin A, spermidine, resveratrol, and adaptogens — not as exercise replacements, but as precision amplifiers that help you stay in the “Goldilocks zone.”
(Educational content only, not medical advice.)
-
References From Episode:
Mechanistic Modulation of Autophagy by Bioactive Natural Products: Implications for Human Aging and Longevity
Early mitophagy activation by Urolithin A prevents, but late activation does not reverse, age-related cognitive impairment
Mitophagy as a therapeutic target for exercise-induced fatigue: modulation by natural compounds and mechanistic insights
Mitophagy in Alzheimer’s disease and its potential as a therapeutic target
-
Key Quotes From Episode:
“Mitophagy is the scrapyard.”
“If the trash isn’t being collected, your cells become crowded with clunker mitochondria.”
“We are fundamentally as young as our mitochondrial recycling program.”
Regarding Urolithin A: “The supplement isn’t a replacement for the gym. It’s an amplifier.”
“You cannot supplement your way out of a sedentary lifestyle.”
-
Key Points
“Clean” diagnoses work for broken bones—not for fatigue/brain fog/aging biology.
Energy comes from mitochondria via OXPHOS, but ROS is the inevitable “exhaust.”
MQC has tiers: biogenesis (PGC-1α) → fusion/fission → mitophagy.
Mitophagy = autophagosome “trash bag” + lysosome “acid vat” → true recycling.
Aging = declining mitophagy → accumulation of “clunker” mitochondria → fatigue + ROS.
Key QC pathway: PINK1/Parkin (membrane potential loss → PINK1 buildup → Parkin ubiquitin “kiss of death” → autophagosome recruitment).
Redundancy matters: receptor routes like FUNDC1 provide rapid hypoxia response.
Alzheimer’s reframing: mitochondrial cascade hypothesis—mitochondrial failure may precede plaques/tangles.
Broken mitochondria leak mtDNA (bacterial-like) → microglial DAMP sensing → NLRP3 inflammasome → IL-1β inflammation.
“Cellular rust”: ferroptosis (iron + lipid peroxidation) via Fenton reaction → hydroxyl radicals → membrane collapse.
Paradox: mitophagy protects—until overdrive overwhelms lysosomes → iron flood → GPX4 overwhelmed → ferroptosis.
Best lever: exercise (hormesis). Acute ROS/hypoxia = signal to “clean house.”
MICT vs HIIT: steady AMPK vs shock AMPK + hypoxia receptors; HIIT higher reward, smaller margin.
Overtraining = “cellular chainsaw”: pathological mitophagy → iron spill → ferroptosis.
Biohacking layer: compounds that tilt AMPK↑ / mTOR↓ (urolithin A, spermidine, resveratrol/SIRT1).
Adaptogens can reduce mitophagy markers in terminal exhaustion by preventing panic-mode autophagy.
Supplements ≠ replacement for exercise; they’re precision optimizers for a systemic “earthquake.”
Actionable thesis: find your personal mitophagy threshold (stimulate cleanup without tipping into rust/inflammation).
-
Episode timeline
00:00–03:30 — Why “engineering-style” diagnoses fail for fatigue/aging/brain fog
03:30–09:00 — OXPHOS explained: electron transport chain, proton gradient, ATP + ROS “exhaust”
09:00–15:00 — MQC stack: biogenesis (PGC-1α) → fusion/fission → mitophagy “scrapyard”
15:00–20:30 — Mitophagy mechanics: autophagosome “trash bag” + lysosome “acid vat” → recycling
20:30–27:30 — Aging: mitophagy slows → clunker mitochondria accumulate → fatigue + ROS acceleration
27:30–36:30 — Molecular detectives: PINK1/Parkin ubiquitin system (membrane potential → tagging → clearance)
36:30–40:30 — Redundant pathways: receptor-mediated “panic buttons” (e.g., FUNDC1 under hypoxia)
40:30–49:30 — Alzheimer’s paradigm shift: mitochondrial cascade hypothesis + amyloid/tau sabotage of QC
49:30–54:30 — Inflammatory spillover: mtDNA as DAMP → microglia → NLRP3 inflammasome → IL-1β
54:30–58:30 — Ferroptosis: iron + Fenton reaction → hydroxyl radicals → lipid peroxidation (“cellular rust”)
58:30–62:00 — Control levers: exercise hormesis; MICT vs HIIT; AMPK→ULK1; recovery window; overtraining risk
62:00–64:00 — Biohacking layer: AMPK↔mTOR seesaw; urolithin A/spermidine/polyphenols/adaptogens + closing synthesis
-
♻️⚡️ Mitophagy → Urolithin A → BioLithin Lite ⚡️♻️
BioLithin Lite is a premium, precision-formulated mitochondrial longevity stack designed for those who want targeted cellular renewal without unnecessary complexity.
Built around clinically-studied Urolithin A and synergistic taurine, BioLithin Lite supports mitophagy — the body’s natural process of recycling worn-out mitochondria — helping promote cleaner cellular energy, healthier aging, enhanced recovery, and long-term mitochondrial resilience.
Minimalist by design yet sophisticated in function, BioLithin Lite delivers foundational mitochondrial support in a streamlined daily formula engineered for sustained performance, vitality, and cellular optimization.

🚨 For the next week, SAVE 20% on your order of BioLithin Lite! 🚨
Discount code: MITOPHAGY20
Expires on 5/14, midnight PST
*must choose "Single" quantity option and then increase to desired amount

Shop BioLithin Lite! ♻️⚡️
-
Dr. Mike's #1 recommendations:
Deuterium depleted water: Litewater (code: DRMIKE)

EMF-mitigating products: Somavedic (code: BIOLIGHT)

Blue light blocking glasses: Ra Optics (code: BIOLIGHT)

Grounding products: Earthing.com
-
Stay up-to-date on social media:
Dr. Mike Belkowski:
Instagram
LinkedIn

BioLight:
Website
Instagram
YouTube
Facebook
1 hr 3 min
May 06Blue Light Is Making Fat “Dumber”: Mitochondrial Damage, Lower Burn Rate, More Obesity
In this Energy Code Deep Dive episode, Dr. Mike breaks down a modern (and slightly unsettling) obesity paper: blue light exposure worsened obesity in high-fat diet–fed mice — not just through “sleep/circadian disruption” in the abstract, but via signals consistent with mitochondrial dysfunction and oxidative stress in subcutaneous white fat. The study compares normal vs high-fat diet mice under white light vs blue light and finds that blue light, in the high-fat context, is associated with more weight/fat gain, worse glucose handling, lower whole-body energy expenditure, and a strong tissue-specific signal in inguinal white adipose tissue (iWAT) — a depot closer to the surface that may be more vulnerable to light penetration. Mechanistically, the paper points toward suppressed oxidative phosphorylation gene expression plus higher ROS/lipid peroxidation and weaker antioxidant defenses in iWAT. The key takeaway: in a high-fat environment, blue light may act like a metabolic amplifier — increasing load while weakening the machinery that should burn fuel cleanly.
(Educational content only, not medical advice.)
-
Article Discussed in Episode:
Blue light exposure exacerbates obesity in high-fat diet-fed mice by inducing mitochondrial dysfunction in the white adipose tissue
-
Key Quotes From Dr. Mike:
“Blue light, obesity, fat tissue, and mitochondrial dysfunction… modern and a little unsettling.”
“Could the kind of light we are increasingly surrounded by actually make metabolic dysfunction worse… by directly damaging the way fat tissue handles energy?”
“In mice eating a high-fat diet, blue light exposure led to more weight gain and more body fat than white light exposure.”
“Blue light exposed high-fat mice had lower oxygen consumption, lower carbon dioxide production, and lower heat production.”
“Light is not just visual information, it is metabolic information.”
-
Key Points
The paper asks: can blue light worsen obesity beyond circadian/sleep effects — via fat-tissue mitochondria?
4 groups: normal diet vs high-fat diet × white light vs blue light exposure.
In high-fat diet mice, blue light → more weight gain + more body fat than white light.
Blue light + high-fat diet → worse glucose tolerance and insulin sensitivity.
Strongest depot effect: inguinal white adipose tissue (iWAT) (subcutaneous, closer to surface).
Visceral depot (e.g., epididymal WAT) showed less pronounced change, supporting “location matters.”
Whole-body physiology: blue light high-fat mice had lower O₂ consumption, CO₂ production, and heat output → lower energy expenditure.
These changes were not explained by obvious differences in movement or food intake (per the transcript summary).
iWAT showed suppressed oxidative phosphorylation-related gene expression.
iWAT also showed higher oxidative stress (↑ROS/↑MDA) and lower antioxidant defenses (↓SOD/↓total antioxidant capacity).
Brown fat showed some “thermogenic markers up” signals, but whole-body heat output was down → possible failed compensation.
-
Episode timeline
0:19–0:47 — Intro + why this paper is “modern and unsettling”
0:47–2:20 — Study design: diet (normal vs high-fat) × light (white vs blue)
2:31–3:43 — Reframing: white fat is active metabolic tissue, not passive storage
3:47–5:09 — Headline outcomes: more fat gain + worse glucose/insulin handling under blue light (high-fat context)
5:14–6:10 — Depot specificity: iWAT (subcutaneous “frontline”) vs deeper visceral fat
6:26–7:47 — Metabolic rate findings: ↓O₂/↓CO₂/↓heat → lower energy expenditure (not just behavior)
7:50–10:26 — Mitochondria + oxidative stress: ↓OXPHOS signals + ↑ROS/↑MDA + ↓antioxidant defenses in iWAT
10:56–12:04 — Brown fat paradox: some thermogenic markers ↑, but whole-body heat ↓ → “failed rescue”
12:09–13:47 — Direct vs indirect mechanism: circadian disruption vs local tissue exposure; what’s still unknown
14:14–16:48 — Final synthesis: light as metabolic information; blue light as an “amplifier” under high-fat stress
-
Dr. Mike's #1 recommendations:
Deuterium depleted water: Litewater (code: DRMIKE)

EMF-mitigating products: Somavedic (code: BIOLIGHT)

Blue light blocking glasses: Ra Optics (code: BIOLIGHT)

Grounding products: Earthing.com
-
Stay up-to-date on social media:
Dr. Mike Belkowski:
Instagram
LinkedIn

BioLight:
Website
Instagram
YouTube
Facebook
18 min
May 05ALS May Start in the Hypothalamus: Early Mitochondrial Failure + Metabolic Circuit Breakdown
In this Energy Code Deep Dive episode, Dr. Mike unpacks a paper that reframes ALS at a deeper level: ALS may begin as an energy regulation failure, starting in the hypothalamus, before it becomes an obvious motor neuron story.The hypothalamus isn’t just “another brain region”; it’s the body’s metabolic control room — governing hunger, energy expenditure, hormones, and fuel signaling. The paper shows that in ALS mouse models, the hypothalamus develops early mitochondrial bioenergetic impairment (including reduced spare respiratory capacity) alongside neuroimmune activation (astrocytes and microglia) and melanocortin circuit disruption (POMC/AgRP imbalance) that could help explain early hypermetabolism and weight loss seen in ALS. Most provocatively, early metabolic modulation (TMZ) restored hypothalamic bioenergetics, reduced glial activation, normalized aspects of circuit signaling, delayed onset, and extended survival — suggesting the “first domino” may be a failing energy command center, not just downstream motor collapse.
(Educational content only, not medical advice.)
-
Article Discussed in Episode:
The hypothalamus is an early site of mitochondrial failure and neuro-immune circuit disruption in amyotrophic lateral sclerosis
-
Key Quotes From Dr. Mike:
“ALS may not begin only as a motor neuron story. It may also begin as an energy regulation story.”
“Mitochondrial dysfunction shows up in the hypothalamus before symptoms begin.”
“If that is true, then ALS is not just a disease of movement. It is also a disease of failed energy coordination.”
“These hypothalamic mitochondrial changes… happened before major motor symptoms.”
“…if you intervene early at the level of hypothalamic energy failure, you may be able to change the trajectory of disease.”
-
Key Points
ALS may not start only in motor neurons; it may start with hypothalamic energy-control failure.
The hypothalamus is the body’s metabolic thermostat/control room (hunger, weight, hormones, energy use).
Hypermetabolism + weight loss are common in ALS and correlate with worse outcomes — this may be upstream, not just secondary.
In ALS models, hypothalamus shows early mitochondrial dysfunction before symptom onset.
Key mitochondrial finding: reduced maximal respiration + reduced spare respiratory capacity (“backup power” loss).
Changes are region-specific: hypothalamus shows the strongest coordinated mitochondrial/inflammatory signature vs hippocampus/cerebellum.
Early astrocyte and microglia activation appears alongside metabolic reprogramming toward glycolysis.
Melanocortin circuitry disruption: decreased POMC neurons, increased AgRP-related signaling → altered energy balance control.
Timing matters: these shifts occur before major motor symptoms, implying causal relevance.
TMZ (trimetazidine) given early restored hypothalamic bioenergetics, reduced glial activation, normalized circuit features, delayed onset, extended survival (mouse data).
-
Episode timeline
0:19–0:34 — Intro + why this paper could change how we think about ALS
0:34–1:55 — The core reframing: ALS as energy coordination failure, not only motor decline
2:02–3:15 — Hypothalamus 101: the body’s metabolic control room + why ALS hypermetabolism matters
3:18–5:43 — Early hypothalamic mitochondrial failure: methods + respiration + spare respiratory capacity explained
5:54–6:50 — Region specificity: why the hypothalamus stands out vs other brain areas
6:55–8:39 — Neuroimmune activation: astrocytes/microglia activation + metabolic shift toward glycolysis
8:41–10:11 — Melanocortin system disruption: POMC/AgRP imbalance as a driver of systemic energy mismanagement
10:15–11:12 — The timing argument: control-system failure may precede visible motor catastrophe
11:23–12:28 — Translational wedge: TMZ restores bioenergetics, calms glia, shifts circuits, delays onset (in mice)
12:48–13:25 — Cross-model relevance: evidence beyond a single ALS model
13:32–16:11 — Final synthesis: ALS as a metabolic command-center disorder plus motor degeneration
-
Dr. Mike's #1 recommendations:
Deuterium depleted water: Litewater (code: DRMIKE)

EMF-mitigating products: Somavedic (code: BIOLIGHT)

Blue light blocking glasses: Ra Optics (code: BIOLIGHT)

Grounding products: Earthing.com
-
Stay up-to-date on social media:
Dr. Mike Belkowski:
Instagram
LinkedIn

BioLight:
Website
Instagram
YouTube
Facebook
17 min
May 04Methylene Blue + Near-Infrared Light: Two Tools, One Mitochondrial Neuroprotection Mechanism
In this Energy Code Deep Dive episode, Dr. Mike breaks down a provocative neuroprotection review: low-dose methylene blue and near-infrared (NIR) light may look like totally different therapies — one is a molecule, one is photons — but the paper argues they converge on the same core target: mitochondrial respiration. You’ll hear a simple “neurons as cities / mitochondria as power plants” model for neurodegeneration, why methylene blue can function like an alternate electron shuttle in the electron transport chain, how NIR light can energize cytochrome oxidase, and why both approaches may widen the neuron’s “energy margin” during stress. The takeaway isn’t “magic cures.” It’s a disciplined mitochondrial lens: improving the power supply may give repair, plasticity, and survival systems the bandwidth to work.
(Educational content only, not medical advice.)
-
Article Discussed in Episode:
Protection against neurodegeneration with low-dose methylene blue and near-infrared light
-
Key Quotes From Dr. Mike:
“Two very different therapies (methylene blue & NIR light) may be helping the brain in basically the same way.”
“Methylene blue, at low doses, appears to help by acting like an alternate electron shuttle.”
“This paper makes the point that methylene blue has a hormetic dose response…”
“…near infrared light is more like directly energizing one of the key turbines in the mitochondrial power plant.”
“Different tools, same target, and that target is mitochondrial respiration.”
“…if you can stabilize mitochondrial respiration, you may be able to widen that energy margin and make neurons harder to kill.”
-
Key Points
The paper’s thesis: two very different interventions may protect neurons via the same mitochondrial mechanism.
Neurodegeneration framed as energy margin collapse (not only plaques/tangles/toxins/inflammation).
Low-dose methylene blue: acts as an alternate electron shuttle → supports electron flow, ATP production.
Dose matters: methylene blue shows hormesis (low dose supportive; higher dose can backfire).
Near-infrared light: photons absorbed by cytochrome oxidase → boosts mitochondrial respiration and ATP.
NIR effects may outlast a session via enzyme induction / capacity signaling (not just a short “boost”).
Unifying mechanism: both interventions enhance oxidative metabolism and support neuronal survival under stress.
Paper reviews multiple model contexts (ischemia, trauma, neurotoxicity, neurodegeneration models, etc.) as “shared bottleneck” evidence.
Practical translation emphasis: target access matters (MB crosses BBB; NIR can reach cortical tissue with correct parameters).
Key caution: mechanism ≠ guaranteed clinical proof; these are credible mitochondrial-support tools, not universal cures.
-
Episode timeline
0:19–0:34 — Show open + why this paper matters
0:34–1:20 — Core premise: different tools, same mitochondrial target
1:22–2:24 — “Neuron as a city” model: neurodegeneration as failing power plants
2:24–4:24 — Methylene blue explained: electron transport chain “extra courier” + hormetic dosing
4:24–5:15 — Cytochrome oxidase focus: why boosting the “end-of-line turbine” matters
5:15–7:24 — Near-infrared light mechanism: photons → cytochrome oxidase → ATP + longer-lasting effects
7:24–8:55 — The unifying mechanism: respiration support → wider “energy margin” → neurons harder to kill
8:55–10:29 — Evidence across models + “target access” (BBB penetration; transcranial penetration)
10:29–11:43 — Why energy support unlocks repair/plasticity outputs (BDNF, synaptogenesis, etc.)
11:43–12:34 — Hormesis again: the “sweet spot” principle for MB and light
12:34–15:25 — Synthesis + disciplined conclusion (not cures; mitochondrial respiration is the lever)
-
Dr. Mike's #1 recommendations:
Deuterium depleted water: Litewater (code: DRMIKE)

EMF-mitigating products: Somavedic (code: BIOLIGHT)

Blue light blocking glasses: Ra Optics (code: BIOLIGHT)

Grounding products: Earthing.com
-
Stay up-to-date on social media:
Dr. Mike Belkowski:
Instagram
LinkedIn

BioLight:
Website
Instagram
YouTube
Facebook
16 min
May 01Shilajit for Real Performance: The “Strength-Under-Fatigue” Study
In this Energy Code Deep Dive episode, Dr. Mike breaks down a practical 8-week human study on shilajit and performance where it actually matters: after fatigue sets in. Recreationally active young men took placebo, 250 mg/day, or 500 mg/day, then got pushed through a brutal leg-extension fatigue protocol to see how much strength they lost — not just how strong they were fresh. The standout finding: in the stronger half of subjects, the 500 mg group preserved significantly more maximal isometric strength post-fatigue — and showed a quieter signal on serum hydroxyproline, a marker often used to reflect collagen/connective-tissue turnover. Bottom line: this paper doesn’t claim “instant strength.” It suggests shilajit may be more interesting as a fatigue-resistance + tissue-support tool — at the right dose, in the right population.
(Educational content only, not medical advice.)
-
Article Discussed in Episode:
The effects of Shilajit supplementation on fatigue-induced decreases in muscular strength and serum hydroxyproline levels
-
Key Quotes From Dr. Mike:
“In that stronger subgroup, the high dose shilait group lost significantly less maximal isometric strength after the fatiguing protocol…”
“So in simple terms, the men taking 500 mg per day of Sheelajit held on to their strength better once fatigue hit.”
“This was not a study showing Shilait magically blocks exercise damage… It is more a study suggesting that over time, the higher dose may support the tissue environment…”
“The strongest and cleanest finding is this… 500 mg per day… helped preserve maximal strength better after fatigue…”
“Sometimes performance support is not about creating more force at the start. Sometimes it is about losing less force when fatigue tries to take it away.”
-
Key Points
The study asks a real-world question: how much strength do you lose when you’re tired?
Design: recreationally active young men; placebo vs 250 mg/day vs 500 mg/day for 8 weeks.
Test: maximal isometric strength pre-fatigue, then 2×50 maximal concentric isokinetic leg extensions, then post-fatigue testing.
Primary performance signal showed up in the upper 50% (stronger subjects): 500 mg/day = less post-fatigue strength loss.
The lower dose (250 mg/day) did not clearly separate from placebo in that stronger subgroup.
Hydroxyproline (HYP) was used as an indirect marker of collagen/connective-tissue breakdown.
In the stronger subgroup, the 500 mg/day group had lower baseline HYP vs low dose and placebo after supplementation.
No big claims of “massive strength gain,” “weight change,” or “muscle growth.” The story is fatigue-retention, not “overnight PRs.”
Mechanistic framing is suggestive (ATP/mitochondrial support is discussed), but the study itself is performance + serum marker, not deep mitochondrial assays.
Limitations: young men only, specific fatigue model (concentric-dominant), and funding/source considerations.
-
Episode timeline
0:19–0:34 — Show open + setup for a shilajit performance Deep Dive
0:34–1:30 — The question: 8 weeks of shilajit—does it help strength retention under fatigue + connective tissue signals?
1:38–2:14 — What shilajit is (Ayurvedic mineral-rich exudate; fulvic acids, DBPs, minerals)
2:14–2:58 — Study design: placebo vs 250 mg/day vs 500 mg/day; 8-week supplementation
2:40–3:22 — The fatigue protocol + why “strength loss under fatigue” is the real-world metric
3:27–4:14 — Hydroxyproline explained as a collagen/connective-tissue breakdown signal
4:15–5:01 — Main finding: overall modest, but stronger subgroup shows a clearer effect
4:29–5:36 — Headline: 500 mg/day group lost less maximal isometric strength post-fatigue (in stronger half)
5:36–6:09 — Dose specificity: 250 mg/day didn’t separate clearly; possible threshold effect at 500 mg
6:13–7:38 — Hydroxyproline results + why the concentric-only protocol matters for interpretation
7:59–9:04 — Mechanistic framing (ATP/mitochondria discussion as a plausible lens)
9:04–10:31 — What the study did not show + disciplined interpretation
10:35–11:15 — Limitations + conflict-of-interest note
11:19–13:49 — Synthesis: shilajit as “hold the line under fatigue” support + wrap
-
Dr. Mike's #1 recommendations:
Deuterium depleted water: Litewater (code: DRMIKE)

EMF-mitigating products: Somavedic (code: BIOLIGHT)

Blue light blocking glasses: Ra Optics (code: BIOLIGHT)

Grounding products: Earthing.com
-
Stay up-to-date on social media:
Dr. Mike Belkowski:
Instagram
LinkedIn

BioLight:
Website
Instagram
YouTube
Facebook
15 min
April 30BioShilajit: Stop Borrowing Energy From Tomorrow (The 3-Part Mitochondrial Stack)
Dr. Mike unveils BioShilajit — a “trio stack” built for mitochondrial performance: shilajit for ionic minerals + fulvic/humic support, PQQ to signal mitochondrial biogenesis (PGC-1α), and pharmaceutical-grade methylene blue as a low-dose electron-cycling “failsafe” for the respiratory chain.
Along the way, he breaks down why chronic fatigue and brain fog often evade standard labs, walks through the origin story and chemistry of shilajit, highlights ATP and endurance data, explains PQQ’s unique role in building new “cellular engines,” and tells the bizarre history of methylene blue — from textile dye to essential emergency medicine — before tying it all together as structure + supply + backup mechanics for cellular energy. He closes with launch details, the first-week discount code, and where to find the full resource library on the BioLight product page.
(Educational content only, not medical advice.)
-
Article Discussed in Episode:
Fullerenes as Anti-Aging Antioxidants
-
Key Quotes From Dr. Mike:
Regarding BioShilajit: "A mountain resin, a bacterium, and a clothing dye… sounds like quite the trio.”
“Shilajit roughly translates to: the conqueror of mountains and destroyer of weakness.”
“Shilajit contains over 85 distinct trace minerals — and the key word is bioavailable.”
“Shilajit is the pharmacological opposite of a stimulant — it doesn’t tape over the check-engine light; it helps the cell produce more of its own ATP.”
“A microscopic picomolar concentration of PQQ can execute thousands — sometimes tens of thousands — of redox cycles without breaking down.”
“PQQ triggers this exact same genetic alarm bell (PGC-1α -> mitogenesis) — but without the ten-mile run.”
“Inside damaged mitochondria, methylene blue’s mechanism is bypassing the blockade (blockages in the ETC).”
-
Key Points
Two BioLight events + one roadmap: Beyond Conference (Austin, May 27–29), Return to Nature (Franklin, June 11–12), and a tentative A4M plan (December).
Core thesis: chronic fatigue/brain fog often reflects micro-level mitochondrial “power grid” failure, not a single broken marker on standard labs.
BioShilajit = “unlikely trio”: shilajit + PQQ + methylene blue designed as a closed-loop energy system.
Shilajit basics: paleo-humus resin rich in fulvic/humic acids, DBP-like compounds, and ionic trace minerals for high absorption.
ATP angle: shilajit framed as ATP preservation + ETC enzyme protection under stress (mouse forced-swim model described).
Stimulant vs metabolic: shilajit positioned as the opposite of “masking fatigue” (caffeine analogy).
PQQ: framed as a catalytic redox molecule tied to mitochondrial biogenesis via PGC-1α / CREB signaling.
Methylene blue: framed as a low-dose electron cycler that can bypass bottlenecks in the ETC, especially relevant to brain energy.
Safety/precision: strong emphasis on dose hormesis + USP pharmaceutical grade only (avoid aquarium/industrial impurities).
-
Episode timeline
00:01:07–00:03:37 — Beyond Conference (Austin, May 27–29): booth location + product teases
00:03:56–00:05:58 — Speaking topics + Return to Nature (Franklin, June 11–12) + vibe contrast
00:06:13–00:06:51 — Tentative A4M (December) + lead-in to minerals line
00:06:51–00:07:59 — Minerals stack → pivot to BioShilajit announcement
00:07:59–00:10:23 — Why “binary medicine” fails fatigue/brain fog; “wrong level” diagnosis
00:10:24–00:12:34 — The “unlikely trio” frame: mountain resin + bacterial cofactor + blue dye
00:12:43–00:16:40 — Shilajit origin stories + sensory reality + what it is (paleo-humus)
00:20:14–00:22:17 — Molecular payload: fulvic/humic acids + trace minerals + safety/purity note
00:22:26–00:29:32 — Evidence + mechanisms: ATP/fatigue model + “not a stimulant” analogy
00:29:32–00:34:02 — Hormones + cognition: testosterone study overview + tau aggregation discussion
00:34:02–00:39:10 — Shilajit “matchmaker” model: fulvic delivery + DBP-style mitochondrial cleanup
00:39:10–00:48:53 — PQQ deep dive: discovery, “vitamin-like” role, redox cycling, biogenesis signaling
00:49:24–01:05:24 — Methylene blue: history → ETC bypass model → brain relevance → dose/sourcing warnings
01:05:24–01:12:25 — Closed-loop synergy: build engines (PQQ) + supply/protect (shilajit) + failsafe (MB)
01:12:25–01:15:48 — Launch details + discount code + deadline (through May 7)
01:15:54–01:18:41 — Product page “mini-library” + shoutout + closing
-
For the next week, save 20% on your order of BioShilajit!

And for the next week ONLY, you can combine this 20% discount with the Subscribe and Save 10% discount option* (choose on the product page when adding to cart).

This limited-time offer provides you with a 30% discount on BioShilajit and you will retain this exclusive discount of the lifetime of your subscription.

Discount code: BIOSHILAJIT20

Expires on 5/7, midnight PST

*must choose "Single" quantity option and then increase to desired amount

Shop BioShilajit!
-
Dr. Mike's #1 recommendations:
Deuterium depleted water: Litewater (code: DRMIKE)

EMF-mitigating products: Somavedic (code: BIOLIGHT)

Blue light blocking glasses: Ra Optics (code: BIOLIGHT)

Grounding products: Earthing.com
-
Stay up-to-date on social media:
Dr. Mike Belkowski:
Instagram
LinkedIn

BioLight:
Website
Instagram
YouTube
Facebook
1 hr 20 min
April 29C60 Fullerenes: The Soccer-Ball Molecule That Might Slow Aging
What if one of the strangest molecules in biology — the carbon “nanoball” known as C60 — could meaningfully influence aging? In this Energy Code Deep Dive, Dr. Mike breaks down the paper “Fullerenes as Anti-Aging Antioxidants” and explores why fullerenes have become a lightning-rod topic in longevity.
You’ll learn what fullerenes are, why their electron-handling chemistry makes them different from typical antioxidants, and how the review frames their potential role in oxidative stress and mitochondrial function. We unpack the famous C60-in-olive-oil lifespan study, the proposed mechanisms (from “radical sponge” behavior to a more strategic mitochondrial ROS-reduction hypothesis), and the most important caveat: context and formulation can flip the biology. Preparation, dose, impurities, and even light exposure can shift fullerenes from promising to problematic—so this episode is about the science, the signal, and the safety questions that still need answers.
(Educational content only, not medical advice.)
-
Article Discussed in Episode:
Fullerenes as Anti-Aging Antioxidants
-
Key Quotes From Dr. Mike:
“These molecules (Carbon 60) can accept electrons… interact with free radicals… and move through lipid membranes.”
“ROS are like sparks coming off a machine… a few sparks are normal, too many sparks start causing damage.”
“Fullerenes can accumulate in mitochondria… placing a fire extinguisher inside the power plant itself.”
“Now the fullerene is not just cleaning up sparks after they happen, it may be reducing how many sparks the mitochondrial power plant throws off in the first place.”
“Sometimes the most interesting ideas in anti-aging science are not the ones that sound familiar.”
-
Key Points
What fullerenes are: spherical carbon cages; C60 = 60 carbon atoms in a “soccer-ball” structure.
Why the hype exists: they can accept electrons, interact with free radicals, and move through lipid membranes.
Aging framework: ties into the free radical/mitochondrial oxidative stress model of aging.
The headline animal finding: C60 dissolved in olive oil was associated with a large lifespan increase in rats (not a human claim).
How they may work: not only scavenging ROS, but possibly triggering protective pathways.
Mitochondria angle: evidence suggests mitochondrial accumulation, potentially changing ROS “at the source.”
Provocative mechanism hypothesis: fullerenes may behave like a mild “pressure release valve” (uncoupler-like behavior) in mitochondria.
Critical caution: biology is context-dependent — prep, dose, surface chemistry, impurities, and light can shift effects.
Safety reality: mixed findings across studies; the review treats this as a platform with variable outcomes.
Bottom line: compelling early signals, but not a validated human anti-aging therapy.
-
Episode timeline
0:47–1:41 — What fullerenes are: C60, the carbon “soccer ball”
1:41–2:18 — Why longevity cares: electrons, radicals, membranes, mitochondria
2:19–3:35 — Free-radical theory → mitochondria as the “spark source”
3:46–4:16 — The non-simple story: beneficial vs harmful effects
4:23–5:30 — Anti-aging evidence overview + the famous C60/olive-oil rat study (with realism)
5:54–6:33 — “Radical sponge” concept + SOD-mimic derivatives
6:42–7:31 — City analogy + the idea that fullerenes may also trigger endogenous defenses
7:40–9:38 — Mitochondria deep dive: accumulation + mild “uncoupler/pressure-valve” hypothesis
10:03–11:23 — Toxicity + why formulation and context can flip outcomes
11:24–12:11 — Broad application claims + why that’s both exciting and cautionary
12:11–15:21 — The real takeaway: promise, limits, unanswered questions + closing
-
Dr. Mike's #1 recommendations:
Deuterium depleted water: Litewater (code: DRMIKE)

EMF-mitigating products: Somavedic (code: BIOLIGHT)

Blue light blocking glasses: Ra Optics (code: BIOLIGHT)

Grounding products: Earthing.com
-
Stay up-to-date on social media:
Dr. Mike Belkowski:
Instagram
LinkedIn

BioLight:
Website
Instagram
YouTube
Facebook
16 min
April 28Better Mitochondria, Not Just More: Urolithin A’s Human Trial Explained
In this Deep Dive episode, Dr. Mike breaks down a landmark first-in-human study on urolithin A — one of the most important translational steps yet in mitochondrial longevity science. The paper asks the question the field has been waiting for: when you target mitophagy (the selective cleanup of damaged mitochondria) in real humans, does it appear safe, does it reach the bloodstream and tissue, and does it actually shift biology in the direction of healthier mitochondrial function?
You’ll learn why urolithin A is different from typical “mitochondria boosters,” how the study tested safety, tolerability, and bioavailability, and why it matters that urolithin A was detected in skeletal muscle. Dr. Mike also explains the key biomarker signals—like reductions in plasma acylcarnitines — and the muscle gene-expression changes that suggest a coordinated mitochondrial health signature, including comparisons to patterns seen in healthier, more active older adults. The takeaway: this study doesn’t prove performance gains yet — but it strongly supports that mitochondrial quality control is a targetable human biology, and it opens the door for larger efficacy trials.
(Educational content only, not medical advice.)
-
Article Discussed in Episode:
The mitophagy activator urolithin A is safe and induces a molecular signature of improved mitochondrial and cellular health in humans
-
Key Quotes From Dr. Mike:
“Aging is also the progressive failure of mitochondrial quality control.”
“Instead of just trying to stimulate mitochondria harder… (with urolithin A) you are trying to improve the quality of the mitochondrial population itself.”
“Urolithin A was detectable in skeletal muscle after oral dosing…”
“This is not just a paper saying urolithin A is present in blood… the muscle is responding with a transcriptional program consistent with improved mitochondrial health.”
“The molecular signature induced by urolithin A resembles aspects of what is seen with regular exercise.”
-
Key Points
Why it matters: A “mitophagy-first” intervention is tested in humans, not just cells or animals.
Study design: Randomized, double-blind, placebo-controlled Phase 1 in healthy sedentary older adults, with single- and multiple-ascending dose arms (28 days).
Safety: Favorable profile, no serious adverse events reported; no major lab/ECG concerns noted in the transcript.
Bioavailability: Detectable in plasma across doses; dose-dependent exposure from 250–1000 mg.
Tissue access: Detectable in skeletal muscle, which is critical for the aging-muscle thesis.
Metabolic signal: Reduced plasma acylcarnitines, consistent with improved mitochondrial fuel handling.
Muscle response: Dose-dependent upregulation of mitochondrial/mitophagy-related gene programs; examples mentioned include GABARAPL1 and FABP3.
Systems-level finding: Gene-set patterns shift toward a profile more consistent with healthier muscle biology.
Exercise resemblance: The molecular signature overlaps with aspects of exercise adaptation — without claiming equivalence.
Limitation: No functional endpoints (strength, walking speed) due to short duration — this is a foundational mechanistic/PK/biomarker study.
-
Episode timeline
0:51–1:34 — Why this paper is a “turning point” (from mice to humans)
1:34–2:38 — What urolithin A is + why mitophagy is the target
2:38–3:47 — Aging as mitochondrial quality-control failure; why muscle is the proving ground
3:47–4:46 — Trial design: randomized, double-blind, placebo-controlled Phase 1; single vs multiple ascending dose
4:46–5:39 — Safety & tolerability overview
5:39–6:57 — Pharmacokinetics: plasma exposure, dose-dependence, conjugates, and skeletal muscle detection
6:57–7:36 — Practical translational detail: minimal food effect (yogurt matrix)
7:36–9:14 — Biomarker signal: acylcarnitines as a window into fatty-acid oxidation efficiency
9:14–10:57 — Muscle biopsy findings: gene expression shifts (mitophagy/mitochondrial programs)
10:57–12:29 — Transcriptomics + “directional rescue” vs pre-frail sedentary signatures
12:29–13:53 — Exercise-like signature (with explicit caveats)
13:53–14:57 — Limitations: no performance outcomes yet; why that’s expected in 4 weeks
14:57–16:25 — Evidence hierarchy: safety → PK → biomarkers → then larger trials
16:25–17:07 — Why supplementation matters: microbiome variability makes food-derived production inconsistent
17:07–19:31 — Final synthesis: mitophagy/quality control as a targetable human pathway + closing
-
Dr. Mike's #1 recommendations:
Deuterium depleted water: Litewater (code: DRMIKE)

EMF-mitigating products: Somavedic (code: BIOLIGHT)

Blue light blocking glasses: Ra Optics (code: BIOLIGHT)

Grounding products: Earthing.com
-
Stay up-to-date on social media:
Dr. Mike Belkowski:
Instagram
LinkedIn

BioLight:
Website
Instagram
YouTube
Facebook
20 min

About The Energy Code

From the publisher's feed

The Energy Code is your blueprint for unlocking limitless vitality at the cellular level. Hosted by Dr. Mike Belkowski, this podcast dives deep into the science of your mitochondria—the true…